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Background: The acute hospital is a challenging place for a person with dementia. Behavioural and
psychological symptoms of dementia (BPSD) are common and may be exacerbated by the hospital
environment. Concerns have been raised about how BPSD are managed in this setting and about over
reliance on neuroleptic medication. This study aimed to investigate how BPSD are managed in UK
acute hospitals.
Method(s): A longitudinal cohort of 230 patients with dementia admitted to two acute NHS hospitals.
BPSD were measured every four days (Behave-AD scale), as well as documentation of pharmacological
prescriptions and non-pharmacological management.
Results: The overall prevalence of BPSD was 75%, with aggression and activity disturbance being the
most common. Antipsychotics were prescribed for 28 (12%) patients; 70% of these prescriptions were
new on admission. Benzodiazepines were prescribed for 27 (12%) patients, antidepressants were
prescribed for 37 (16%) patients, and sedatives were prescribed for 14 (3%) patients. Patients who were
prescribed antipsychotics, after adjusting for end of life medication, age and dementia severity, were
signiﬁcantly more likely to die (adjusted hazard ratio 5.78, 95% CI 1.57, 21.26, p=0.008). Non-
pharmacological management was used in 55% of participants, most commonly psychosocial
interventions (36%) with little evidence of monitoring their effectiveness. A form of restraint was used
during 50 (22%) patients’ admissions.
Conclusions: Antipsychotic medications and psychosocial interventions were the main methods used to
manage BPSD; however, these were not implemented or monitored in a systematic fashion.
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Introduction
People with dementia are frequently admitted to acute
general hospitals (Russ et al., 2012; Mukadam and
Sampson, 2011), and this is a challenging environment
for them. In addition to being physically unwell, the
person is in strange surroundings, with unfamiliar
and changing staff. Behavioural and psychological
symptoms of dementia (BPSD) include symptoms
such as agitation, aggression, affective disorder, and
sleep disturbance. These symptoms can be difﬁcult to
manage, cause signiﬁcant distress to family and
professional caregivers, and are often exacerbated
during an acute hospital admission (Kales et al.,
2015; Freeman and Joska, 2012; Banerjee, 2010;
Lyketsos et al., 2014). Up to 75% of people with
dementia admitted to the acute hospital will
experience BSPD (Sampson et al., 2014). A UK
national audit, the ‘National Audit of Dementia Care
in General Hospitals’ found only 5% of acute hospital
staff receive mandatory training in dementia, and one
third felt that there were insufﬁcient staff to meet the
need of patients (2011). Many ward staff feel that they
lack the skills and conﬁdence to work with ‘confused’
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patients (Grifﬁths et al., 2014). A randomised
controlled trial (Goldberg et al., 2013) found that a
specialist inpatient ward for people with dementia
did not signiﬁcantly reduce BPSD nor reduce
admission, but it did improve the experience of the
patient and their family members.
In care homes, non-pharmacological interventions
have been shown to decrease BPSD for people with
dementia and improve the general well-being of the
carer (Kales et al., 2015; Deudon et al., 2009;
Livingston et al., 2005). However, it has been found
that pharmacological interventions, speciﬁcally
antipsychotics, are often used before non-
pharmacological alternatives (Cohen-Mansﬁeld,
2013) despite the increased risk of mortality and
adverse events such as seizures, weight gain, or
extrapyramidal symptoms (Langballe et al., 2014;
Gauthier et al., 2010; Ballard and Corbett, 2010). We
have little detailed data describing how BPSD are
managed in acute hospitals. Given the recent focus
on decreasing neuroleptic use in people with dementia
(Banerjee, 2010) this information could inform better
care for these patients.
Aim
The aim of this study was to describe the
pharmacological and non-pharmacological management
of BPSD in people with dementia over the age of
70 years who had undergone unplanned acute hospital
admission.
Speciﬁc questions were as follows:
(1) How commonly are pharmacological interventions
for BPSD prescribed in this setting?
(2) Which patient characteristics and BPSD symptoms
are associated with pharmacological management?
(3) Is there an association between antipsychotic
medication and mortality in this setting?
(4) What type of non-pharmacological management
techniques are being used to manage BPSD, and
how frequently?
Methods
Study design
Longitudinal cohort data were collected as part of a
larger study investigating BPSD and pain in people
with dementia in the acute hospital (Scott et al.,
2011; Sampson et al., 2015). This study received
ethical approval by Central London REC 3 on 01/12/
2010 (ref: 10/HO716/79).
Setting
Two NHS acute hospitals within the Greater London
area serve over two million people encompassing
socioeconomic and ethnic diversity. Between them,
the hospitals cover six primary care trusts and four
mental health trusts. They were chosen because they
were at different stages of implementing the English
National Dementia Strategy with varying provision of
liaison psychiatry and service quality rating scores.
Researchers spent 5months at each site (between 4
April 2011 and 6 March 2012). In both settings,
patients were admitted via a medical acute admissions
unit before transfer to an elderly care ward or a general
medical ward (total of 20 wards).
Participants
All patients admitted to the hospital with an
unplanned acute medical admission, over the age of
70, with English language sufﬁcient to complete
cognitive testing, and an Abbreviated Mental Test
(AMT), completed as part of the admission
(Hodkinson, 1972) score of less than 7 were eligible
for screening.
Screening
At the time of this study, dementia was commonly
under-detected in the UK. We therefore needed to
try and include those patients who had dementia but
had no pre-existing documented diagnosis, whilst
excluding those who were cognitively impaired
because of delirium. Therefore, all patients who met
the study criteria were screened for delirium using
the Confusion Assessment Method (CAM) (Inouye
et al., 1990) by a research assistant. The CAM tool
has a sensitivity of 94% and speciﬁcity of over 90%
for detecting delirium and distinguishing accurately
between delirium and dementia (Inouye et al., 1990).
• Patients with a pre-existing diagnosis of dementia,
documented in the medical notes, were approached
to participate regardless of the CAM score.
• Patients with no pre-existing diagnosis of dementia
who screened negatively for delirium were
approached to participate.
• Patients with no pre-existing diagnosis of dementia
who screened positive for delirium were re-
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screened 48hours later. At this time point, if the
delirium had cleared, they were approached to
participate. If the delirium was unresolved, they
were excluded.
We used the consent guidelines for adults who lacked
capacity within the Mental Capacity Act (2005). All
patients underwent a capacity assessment with a
research assistant. Those with capacity were asked to
complete a consent form. When patients lacked
capacity, agreement was requested from a personal
consultee. In the absence of a personal consultee, a
professional consultee was employed (Scott et al., 2011).
All consented participants completed a Mini
Mental State Examination (MMSE). Patients with no
history of dementia were excluded if they scored over
24 and did not meet the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition criteria
for dementia.
Assessments
Demographic characteristics such as age, gender,
ethnicity, dementia severity using the Functional
Assessment Staging Tool (FAST) (Reisberg, 1988),
and marital status were gathered on each patient from
hospital notes.
The behaviour pathology in Alzheimer’s disease rating
scale. The Behaviour Pathology in Alzheimer’s disease
Rating Scale (BEHAVE-AD) (Sclan et al., 1996) was used
to assess BPSD. It consists of 25 items which are divided
in to seven subgroups; paranoid and delusional ideation,
hallucinations, activity disturbances, aggression, diurnal
disturbances, affective disturbances, anxieties, and
phobias. Each subgroup is scored on a 4-point scale from
0 to 3, 3 being the most severe score. The BEHAVE-AD
has good internal consistency and reliability and
sensitive to longitudinal changes (Sclan et al., 1996).
Pharmacological management. Prescriptions of
antipsychotics, antidepressant, cholinesterase inhibitors,
benzodiazepines, and sedatives were recorded from drug
charts at each assessment. We documented whether
antipsychotics were newly prescribed during this
admission or whether the patient had been on these
medications when admitted.
Non-pharmacological management. Non-pharmacological
management was deﬁned as any intervention put in
place by the ward team that did not involve medication
and was used with the intention to manage BPSD.
Interventions were identiﬁed by speaking to the clinical
team, often the nurse, responsible for the patient’s care
and asking how they were managing any BPSD,
examining medical notes for any documentation of this
since the patient’s admission, and by observations on
the wards whilst gathering information on the patient.
A list of overall types of non-pharmacological
interventions was developed from the types of
interventions employed by the staff speciﬁcally to
manage BPSD. This list was veriﬁed by two
independent raters. The categories were ‘Equipment’
incorporated the use of hospital beds, hoists (where
used in the context of managing behaviours), a safety
mat, or a falls alarm to aid the ward staff in managing
the BPSD. ‘Family assistance’ were instances when the
family had been called in speciﬁcally to help manage
the BPSD. ‘Psycho-social techniques’ were techniques
used by the healthcare professionals, consisting usually
verbal prompts such as reorientation to time and
place, allowing the patient to wander on the ward,
individual care plans for confusion, or behaviour
charts. ‘Increased stafﬁng’ were instances of patients
being moved to a high visibility bay, requiring close
supervision, or one to one stafﬁng. ‘Specialist referral’
were instances when the patient was referred to a
Psychiatry or Psychology team. ‘Other therapy’
incorporated any complementary therapy that the
patient was referred to, for example massage, spiritual
support, and music therapy.
In addition to the non-pharmacological interventions,
we documented periods where the team had to restrain
the patient. ‘Restraint’ incorporated any barrier to limit
the patient’s activities, for example mittens, nasogastric
tubes with bridles, raised bed rails, and physical
restraint.
Follow-up assessments. Data on the BEHAVE-AD,
pharmacological prescribing, and non-pharmacological
management were collected every four days until death
or discharge, or until patients were deemed ‘medically
ﬁt for discharge/awaiting placement’ by their medical
team. At each follow-up assessment, any monitoring
or measures of effectiveness of the intervention being
used, as well as any changes since the previous
assessment, were documented.
Data analysis
Patient demographics were described. The prevalence of
BPSD, antipsychotic use, and non-pharmacological
management were calculated by dichotomising each
variable in to present/absent at any point during the
admission. Presence of a BPSD was deﬁned as reaching
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a BEHAVE-AD score above 0 for at least one of the
assessments. The mean BPSD score was calculated from
the patients’ BEHAVE-AD ratings over the admission.
We used chi-squared tests and logistic regression to
investigate the association of patient characteristics
with speciﬁc BPSD (as indicated by the BEHAVE-
AD) with the use of antipsychotic medication during
the admission. We explored the association between
the use of antipsychotics and mortality with a cox
regression survival analysis. Because the number of
mortality events was small, a multivariable model with
too many adjustment covariates can be unstable; we
therefore restricted to adjust for two main
confounders (age and dementia severity) in the main
analysis. We completed a sensitivity analysis to exclude
those patients who were on an end of life care plan and
may have been receiving these medications as part of
that treatment plan. To explore how results could
change with further adjustment we also performed a
sensitivity analysis fully adjusted for age, dementia
severity, presence of delirium, and psychiatric history.
When BPSD were present during admission we
tabulated the frequency and 95% conﬁdence interval
(CI) of use of each type of non-pharmacological
management. Analyses were two-sided and considered
signiﬁcant when signiﬁcance level was below 0.05.
Analyses were conducted using STATA v13.0.
Results
Of the 292 participants approached, 230 had
dementia, were consented and entered the study (refer
to Study ﬂow chart Appendix 1). For cohort
characteristics, refer to Table 1.
Prevalence of BPSD
Three quarters (74.8%) of participants experienced at
least one BPSD during their admission (Table 1).
Aggression was the most frequent type of BPSD with
over half of the participants experiencing this at least
once during the admission 56.5%, (95% CI 50–63).
Activity disturbance occurred in 43.9% (95% CI 37–
50) and sleep disturbance in 42.2% (95% CI 36–49).
The admission and the course of the BPSD over
admission are discussed as part of the larger study
(Sampson et al., 2014; Sampson et al., 2015).
Pharmacological management of BPSD
An antipsychotic was prescribed on at least one
occasion during admission to 28 participants (12.2%)
(Table 2). Of these, 19/28 (67.9%) of participants were
new prescriptions during this admission. None of
those prescribed antipsychotics had cognitive capacity
to give their consent for participation in the study
and 7/28 (25%) had delirium on admission. Ten
(36%) had a pre-existing mental health diagnosis, nine
(32%) had severe dementia and were at stage 7 of the
FAST score, and 15/28 (54%) of participants were in
stage 6 of the FAST. Over a third of those who were
prescribed an antipsychotic died during their
admission.
Out of the 230 participants recruited, the
prevalence of other medications prescribed during an
admission were benzodiazepines 27/230 (12%),
Table 1 Cohort characteristics
(n = 230) Total (%)
Gender
Female 151 65.7
Male 79 34.3
Ethnicity
White British 175 76.1
Black Caribbean 15 6.5
Other 40 17.4
FAST
3–5 86 37.4
6a–6c 39 16.9
6d–6e 74 32.2
7a–7f 31 13.5
Age
75–84 85 37.0
85–94 118 51.3
95+ 27 11.7
Place of residence (/219)
Home/sheltered 145 66.2
Residential home 26 11.9
Nursing home 39 17.8
Other 9 4.1
Reason for admission (/229)
Infection–lungs/skin/viral 79 34.5
Infection–UTI/blocked catheter 36 15.7
Fall/fracture/pain 31 13.5
Cardiac 22 9.6
Other 61 26.7
Delirium on baseline (/227)
Yes 26 11.4
No 201 88.6
Died during admission
Yes 30 13.0
No 200 87.0
Previous psychiatric history
Yes 46 20.0
No 184 80.0
BPSD experienced during admission:
Any BPSD 172 74.8
Paranoia 26 11.3
Hallucination 34 14.8
Activity disturbance 101 43.9
Aggression 130 56.5
Sleep disturbance 97 42.2
Affective 77 33.5
Anxiety 81 35.2
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antidepressants 37/230 (16%) cholinesterase
inhibitors 35/230 (15%), and sedative-hypnotics
14/230 (6%).
Factors associated with pharmacological management
at any time during admission.
Gender and age were not signiﬁcantly associated with
antipsychotic, anti-depressant, benzodiazepine, or
sedative prescribing (Table 3). For every category
increase on the FAST tool, patients were 26% more
likely to have an antipsychotic prescribed during their
admission (OR 1.26, 95% CI 1.09, 1.46, p=0.002).
Patients with any form of BPSD during their
admission were ﬁve times more likely to have an
antipsychotic prescribed during the admission (OR
4.99, 95% CI 1.15, 21.70, p=0.032). Antipsychotic
prescription was ﬁve times more likely in people who
experienced hallucinations (OR 5.04, 95% CI 2.10,
12.06, p≤0.001) or activity disturbances (OR 5.71,
95% CI 2.22, 14.70, p≤0.001) and seven times more
likely with aggressive behaviours (OR 7.70, 95% CI
2.25, 26.31, p=0.001). Patients were three times more
likely to have an antipsychotic prescribed when they
experienced sleep disturbance (OR 3.35, 95% CI
1.45, 7.79, p=0.005).
Prescription of benzodiazepine was associated with
anxiety (OR 2.59, 95% CI 1.15, 5.86, p=0.022). The
prescription of antidepressants and sedatives was not
signiﬁcantly associated with BPSD overall or by
subgroups.
Patients prescribed antipsychotics had a higher risk
of mortality during admission ( hazard ratio (HR)
3.19, 95% CI 1.49, 6.83, p=0.003). This association
remained signiﬁcant after adjustment for age and
dementia severity (HR 2.78, 95% CI 1.27, 6.07;
Table 2 Antipsychotics use and non-pharmacological management at
any time during admission (n = 230)
Pharmacological management N % 95% CI
Antipsychotic 28 12.2 8–17
Antidepressant 37 16.1 12–21
Benzodiazepine 27 11.7 8–17
Sedative 14 6.1 03–10
Cholinesterase Inhibitors 35 15 11–202
Non-pharmacological management
Any 126 54.8 48–61
Equipment 17 7.4 4–12
Family assistance 14 6.1 3–10
Psychosocial intervention 83 36.1 30–43
Staffing 38 16.5 12–22
Restraint 50 21.7 17–28
Specialist referral 23 10.0 6–15
Other therapy 3 1.3 0–4
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p=0.010). In a sensitivity analysis, where participants
on an end of life care regime were excluded, the
association between mortality and antipsychotics
remained signiﬁcant, whilst still adjusting for age and
dementia severity (HR 5.78, 95% CI 1.57, 21.26,
p=0.008). In an exploratory analysis, the association
adjusted for age, previous psychiatric history,
dementia severity, and delirium on admission, the
association became non-signiﬁcant (HR 1.45, 95%
CI 0.39, 5.32, p=0.577).
Non-pharmacological management of BPSD
In total, 55% of participants received non-
pharmacological management during their admission.
Themost commonly used techniques were psychosocial
interventions (36%) and stafﬁng (17%) (Table 2). We
found no evidence in the nursing or medical notes of
ongoing monitoring or review of the effectiveness of
these non-pharmacological interventions, or of a
systematic way of using these techniques.
Restraint was used during 50 (22%) patients’
admissions. In 119 of the 128 individual incidents this
consisted of using bed rails (93%). Other forms of
restraint were restricting the patients’ ability to remove
a naso-gastric tube, that is by the use of mittens, or
preventing the patient from removing the oxygen mask
by holding it in place. Referrals to specialist services,
such as the hospital liaison psychiatry team, occurred
for 23 participants during their admission (10%).
Discussion
Overall, three quarters of the participants experienced
BPSD during their admission. Almost 40% (88/230) of
patients had a pharmacological intervention and 55%
(126/230) had a non-pharmacological intervention at
some point during their admission.
Antipsychotics were prescribed to 12% of patients
during their admission. Over two thirds (70%) of
prescriptions for antipsychotic drugs were new during
this admission. Hallucinations, activity disturbance,
aggression, and sleep disturbance were the subgroups
of BPSD that were more strongly with associated
antipsychotic prescription. This echoes ﬁndings from
carer surveys in Alzheimer’s Society ‘Counting the
Cost’ report (2009). These are more problematic for
healthcare professionals to manage in a busy hospital
and more noticeable, so are more likely to lead to
the prescription of an antipsychotic; patients who are
withdrawn and have ‘less troublesome’ symptoms
such as depression, may not demand such attention.
We found that delirium and dementia severity were
signiﬁcantly associated to the prescription of
antipsychotics. With delirium, and as dementia
severity increases, people not only lose capacity to
make informed decisions, but also lose the ability
to communicate their needs effectively. Whilst the
prescription of antipsychotic medication may be
appropriate in some cases of delirium or severe
BPSD, the risk of stroke or death may outweigh
the beneﬁts for people who are also acutely
physically unwell (Azermai et al., 2012). Our
ﬁndings suggested that mortality was greater in
patients prescribed an antipsychotic; however, after
adjusting for age, previous psychiatric history,
dementia severity, and delirium this relationship
was not signiﬁcant. The confounding inﬂuence of
delirium when investigating mortality in patients
with dementia is consistent with previous research
(Fick et al., 2002).
Half the patients in the study (55%) received some
form of non-pharmacological intervention. Simple
interventions such as allowing the patient to wander,
using simpliﬁed instructions, and re-orientating the
patient to time and place were the most common
techniques used. Other therapies such as
aromatherapy, music, massage, or spiritual support
were used much less frequently (1.3% in this study).
Previous research from long-term settings suggests
that these therapies can be effective in reducing BPSD.
However, these are challenging to implement in a
hospital where staff are managing the acute illness,
lack knowledge or time, and frequently changeover.
Almost a quarter of patients were restrained during
their admission. The most commonly used restraints
were bed rails. The use of restraints may exacerbate
BPSD and can also lead to numerous physical
problems. For example, reducing mobility through
the use of bed rails can lead to an increase risk of deep
vein thrombosis, pressure sores, constipation,
delirium, or chest infections (Evans et al., 2003;
Inouye and Charpentier, 1996). Of the study
population, 201 (87.4%) lacked the capacity to
provide consent to participate in the study. Restraints
with individuals who do not have capacity should only
be used as a last resort with the deprivation being
proportionate to the perceived risk, as outlined by
the Deprivation of Liberty Safeguards within the
Mental Capacity Act (Cairns, 2009).
For patients where a non-pharmacological
intervention was implemented, there was little
evidence of review or monitoring of effectiveness.
Behavioural charts were completed with several
patients; however, these became a replication of the
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nursing notes and did not appear to change the
care plan. This concurs with community studies
which have found that clinicians feel that they do
not have the resources, time, or knowledge required
to implement non-pharmacological intervention
(Ballard et al., 2009; Kales et al., 2015; Bishara
et al., 2009). Recent reports such as ‘Meeting needs
and reducing distress’(2014) and a randomised
controlled trial looking at the effectiveness of
specialist units (Goldberg et al., 2013) are beginning
to detail practical guidance on managing challenging
behaviours within the acute setting; however, more
evidence-based research is needed.
Strengths and limitations
To our knowledge, this is the ﬁrst study which
examines pharmacological and non-pharmacological
management of BPSD within the acute hospital
setting. We were able to recruit a representative
population of people with dementia, including those
with severe dementia.
We acknowledge that during the screening phase
we may have missed patients with dementia. Those
patients who scored more than 7 on the AMT with
no documented diagnosis of dementia were excluded.
Although a standardised tool, it has been shown that
the AMT has a sensitivity rate of 81%.
There are several limitations including potential
reporting bias; when researchers asked hospital staff
about BPSD they were asked to recall what had occurred
over the last four days. It is possible that more
‘troubling’ and overt BPSD were more likely to be
reported. We collected information on the prescription
of antipsychotic but did not discuss the rationale for the
medication with the prescriber, or their decision-
making processes. Prescription of antipsychotics may
have been appropriate in some cases. In addition, we
did not continuously observe ward staff and their
interactions with the person with dementia. They may
have been using non-pharmacological interventions
such as reassurance or diversion whilst caring for the
person but these may have not been documented.
Whilst we have adjusted for factors routinely collected
as part of the larger dataset, we also acknowledge
that there could be residual confounders which
inﬂuenced the prescription of pharmacological or
non-pharmacological interventions.
The method of collecting data on the non-
pharmacological management of BPSD was simple
and naturalistic, with no standardised method of
assessing the effectiveness. The subsequent categories
described in this study were derived from what the
medical team were doing as part of their care.
Research implications
A randomised controlled trial (Goldberg et al., 2013)
found that a specialist inpatient ward for people with
dementia did not signiﬁcantly reduce BPSD but it
did improve the overall experience for patients and
their carers; however, this study did not document
the speciﬁc non-pharmacological interventions that
were implemented in the unit. Our research presents
data on non-pharmacological methods employed by
ward staff to reduce BPSD. We found little
documented evidence that the effectiveness of
interventions was reviewed. Future research can
build upon these ﬁndings by developing and testing
complex interventions, taking into account the need
for stepped implementation of pharmacological and
behavioural management for BPSD.
Clinical implications
The National Audit of Dementia Care in General
Hospitals (2011) found that only 5% of staff had
received training on dementia care and wards are
often understaffed. The management of BPSD in the
acute hospital setting should be supported by
evidence-based research and systematic guidelines for
healthcare professionals of all levels to use, with
built-in monitoring and an escalation to antipsychotic
use when necessary and appropriate. It may be
possible to adapt holistic models of care which have
been developed for the management of BPSD in care
homes, such as the Serial Trial Intervention to the
acute hospital (Kovach et al., 2006).
Conclusions
People with dementia and BPSD present with complex
symptoms exacerbated by an unfamiliar and
distressing environment, acute medical illness, and
in some cases delirium. Rather than two parallel
models for antipsychotic prescribing and non-
pharmacological management, our ﬁndings support
calls for a cohesive model that incorporates the two
paradigms (Livingston et al., 2014).
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Key points
• People with dementia may present with
complex behavioural and psychological
symptoms exacerbated by a difﬁcult
environment, medical illness, and
sometimes delirium.
• In this cohort aggression and activity
disturbance were the most common
behavioural disturbances.
• Antipsychotic medications and simple
“psychosocial” interventions were the main
methods used to manage BPSD; however,
these were not implemented or monitored
in a systematic fashion.
• Patients who were prescribed antipsychotics
were signiﬁcantly more likely to die.
• A form of restraint was used during a ﬁfth of
patients’ admissions.
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